Clinical trial

Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients

NCT00130533

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Capecitabine Normalized identity: capecitabineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE3

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

CapecitabineDRUG · verified · RxNorm: capecitabine

Sponsors & collaborators

Spanish Breast Cancer Research Grouplead sponsor

Hoffmann-La Rochecollaborator

IBEROAMERICAN COALITION FOR BREAST ONCOLOGY RESEARCH (CIBOMA)collaborator

Mapped research locations

MadridSpain6 BarcelonaSpain4 ValenciaSpain3 SevilleSpain2 A CoruñaSpain2 ZaragozaSpain2 MálagaSpain1 AlicanteSpain1 CórdobaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00130533 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.